These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25416281)

  • 1. Etiology of craniofacial malformations in mouse models of blepharophimosis, ptosis and epicanthus inversus syndrome.
    Heude É; Bellessort B; Fontaine A; Hamazaki M; Treier AC; Treier M; Levi G; Narboux-Nême N
    Hum Mol Genet; 2015 Mar; 24(6):1670-81. PubMed ID: 25416281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blepharophimosis-ptosis-epicanthus inversus syndrome plus: deletion 3q22.3q23 in a patient with characteristic facial features and with genital anomalies, spastic diplegia, and speech delay.
    Zahanova S; Meaney B; Łabieniec B; Verdin H; De Baere E; Nowaczyk MJM
    Clin Dysmorphol; 2012 Jan; 21(1):48-52. PubMed ID: 21934608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new FOXL2 gene mutation in a woman with premature ovarian failure and sporadic blepharophimosis-ptosis-epicanthus inversus syndrome.
    Corrêa FJ; Tavares AB; Pereira RW; Abrão MS
    Fertil Steril; 2010 Feb; 93(3):1006.e3-6. PubMed ID: 19969293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characterization and identification of five novel FOXL2 pathogenic variants in a cohort of 12 Mexican subjects with the syndrome of blepharophimosis-ptosis-epicanthus inversus.
    Chacón-Camacho OF; Salgado-Medina A; Alcaraz-Lares N; López-Moreno D; Barragán-Arévalo T; Nava-Castañeda A; Rodríguez-Uribe G; Lieberman E; Rodríguez-Cabrera L; González-Del Angel A; Borbolla AM; Fernández-Hernández L; Graue-Hernández EO; Zenteno JC
    Gene; 2019 Jul; 706():62-68. PubMed ID: 31048069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential apoptotic and proliferative activities of wild-type FOXL2 and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)-associated mutant FOXL2 proteins.
    Kim JH; Bae J
    J Reprod Dev; 2014 Mar; 60(1):14-20. PubMed ID: 24240106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A piggyBac insertion disrupts Foxl2 expression that mimics BPES syndrome in mice.
    Shi F; Ding S; Zhao S; Han M; Zhuang Y; Xu T; Wu X
    Hum Mol Genet; 2014 Jul; 23(14):3792-800. PubMed ID: 24565867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-occurrence of congenital hydronephrosis and FOXL2-associated blepharophimosis, ptosis, epicanthus inversus syndrome (BPES).
    Gulati R; Verdin H; Halanaik D; Bhat BV; De Baere E
    Eur J Med Genet; 2014 Oct; 57(10):576-8. PubMed ID: 25192944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel FOXL2 mutations in two Chinese families with blepharophimosis-ptosis-epicanthus inversus syndrome.
    Xue M; Zheng J; Zhou Q; Hejtmancik JF; Wang Y; Li S
    BMC Med Genet; 2015 Sep; 16():73. PubMed ID: 26323275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology of ovarian failure in blepharophimosis ptosis epicanthus inversus syndrome: FOXL2 is a conserved, early-acting gene in vertebrate ovarian development.
    Loffler KA; Zarkower D; Koopman P
    Endocrinology; 2003 Jul; 144(7):3237-43. PubMed ID: 12810580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel FOXL2 mutations cause blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian insufficiency.
    Yang XW; He WB; Gong F; Li W; Li XR; Zhong CG; Lu GX; Lin G; Du J; Tan YQ
    Mol Genet Genomic Med; 2018 Mar; 6(2):261-267. PubMed ID: 29378385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of FOXL2 detects three novel mutations and an atypical phenotype of blepharophimosis-ptosis-epicanthus inversus syndrome.
    Krepelova A; Simandlova M; Vlckova M; Kuthan P; Vincent AL; Liskova P
    Clin Exp Ophthalmol; 2016 Dec; 44(9):757-762. PubMed ID: 27283035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Analysis of a Novel FOXL2 Indel Mutation in Chinese Families with Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type I.
    Chai P; Li F; Fan J; Jia R; Zhang H; Fan X
    Int J Biol Sci; 2017; 13(8):1019-1028. PubMed ID: 28924383
    [No Abstract]   [Full Text] [Related]  

  • 13. The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.
    Fan J; Zhou Y; Huang X; Zhang L; Yao Y; Song X; Chen J; Hu J; Ge S; Song H; Fan X
    Hum Reprod; 2012 Nov; 27(11):3347-57. PubMed ID: 22926839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into levator muscle dysfunction in a cohort of patients with molecularly confirmed blepharophimosis-ptosis-epicanthus inversus syndrome using high-resolution imaging, anatomic examination, and histopathologic examination.
    Decock CE; De Baere EE; Bauters W; Shah AD; Delaey C; Forsyth R; Leroy BP; Kestelyn P; Claerhout I
    Arch Ophthalmol; 2011 Dec; 129(12):1564-9. PubMed ID: 22159675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel insertion in the FOXL2 gene in a Chilean patient with blepharophimosis ptosis epicanthus inversus syndrome type I.
    Martinez-Aguayo A; Poggi H; Cattani A; Molina M; Romeo E; Lagos M
    J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):181-4. PubMed ID: 24030029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation.
    De Baere E; Dixon MJ; Small KW; Jabs EW; Leroy BP; Devriendt K; Gillerot Y; Mortier G; Meire F; Van Maldergem L; Courtens W; Hjalgrim H; Huang S; Liebaers I; Van Regemorter N; Touraine P; Praphanphoj V; Verloes A; Udar N; Yellore V; Chalukya M; Yelchits S; De Paepe A; Kuttenn F; Fellous M; Veitia R; Messiaen L
    Hum Mol Genet; 2001 Jul; 10(15):1591-600. PubMed ID: 11468277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel mutation in FOXL2 gene that leads to blepharophimosis ptosis epicanthus inversus and telecanthus syndrome in a Tunisian consanguineous family.
    Chouchene I; Derouiche K; Chaabouni A; Cherif L; Amouri A; Largueche L; Abdelhak S; El Matri L
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):145-8. PubMed ID: 19929410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature ovarian insufficiency as a variable feature of blepharophimosis, ptosis, and epicanthus inversus syndrome associated with c.223C > T p.(Leu75Phe) FOXL2 mutation: a case report.
    Grzechocińska B; Warzecha D; Wypchło M; Ploski R; Wielgoś M
    BMC Med Genet; 2019 Jul; 20(1):132. PubMed ID: 31366388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel FOXL2 mutation in a single family with both types of blepharophimosis‑-ptosis-epicanthus inversus syndrome.
    Yang L; Li T; Xing Y
    Mol Med Rep; 2017 Oct; 16(4):5529-5532. PubMed ID: 28849110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.
    Nuovo S; Passeri M; Di Benedetto E; Calanchini M; Meldolesi I; Di Giacomo MC; Petruzzi D; Piemontese MR; Zelante L; Sangiuolo F; Novelli G; Fabbri A; Brancati F
    J Endocrinol Invest; 2016 Feb; 39(2):227-33. PubMed ID: 26100530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.